Diabetes Insights - Breakthroughs and Innovators

• Saving Hearts, Kidneys and Lives in Type 2 Diabetes - Results from the FLOW Trial

  In this episode of Diabetes Insights, we dive into the latest findings from the FLOW Trial - a groundbreaking trial evaluating the impact of GLP-1 receptor agonists on chronic kidney disease (CKD). This discussion features expert insights from Dr. Peter Rossing, Dr. Richard Pratley and Dr. Katherine Tuttle. The results reveal a 24% reduction in kidney disease progression, an 18% decrease in major cardiovascular events, and a 20% drop in total mortality - findings that could reshape clinical practice. Tune in to explore how this research is transforming diabetes and kidney disease management.

  --------  

  17:15
• Can We Screen for Type 2 Diabetes using Voice?

  In this episode of the EASDtv Podcast, we explore a cutting-edge approach to diabetes screening - using voice. Dr Guy Fagherazzi and Dr Abir Elbeji from the Luxembourg Institute of Health discuss their research into how AI-powered voice analysis can detect subtle vocal changes linked to type 2 diabetes. With a growing global burden of undiagnosed diabetes, this technology could provide a scalable, non-invasive screening tool accessible via smartphones. How does it work? How accurate is it? And what does this mean for the future of diabetes care? Tune in to find out how voice-based AI could change the landscape of diabetes screening.

  --------  

  7:46
• Exercise is Medicine - Physical Activity and Insulin Action in Diabetes

  In this episode, we sit down with Prof. Juleen Zierath, recipient of the 2024 EASD-Novo Nordisk Foundation Diabetes Prize for Excellence. A former EASD President, Prof. Zierath shares insights from her pioneering research on the role of exercise in diabetes management, exploring how physical activity can improve glucose metabolism, insulin sensitivity, and overall metabolic health. She also discusses the impact of circadian rhythms on metabolism, the mysteries of insulin action, and the future of precision medicine in diabetes care.

  --------  

  10:27
• Islet Networks Regulating Insulin Secretion - A Debate

  The role of beta cells in diabetes is well established, but how important are the other cells within the islet network? In this episode of Diabetes Insights, Prof. Mark Huising (University of California) and Prof. Guy Rutter (Imperial College London) dive into the intricate crosstalk between islet cells and its impact on insulin secretion and glucose regulation. They debate the influence of alpha and delta cells on beta cell function and explore whether these interactions could hold the key to better diabetes treatments.

  --------  

  9:57
• Diabetologia Journal in Review - Innovations, AI and the Future of Diabetes Research

  In this episode, Prof. Hindrik Mulder, Editor-in-Chief of Diabetologia, joins us to discuss the journals accomplishments over the past year and its vision for the future of diabetes research. From embracing AI in research processes to addressing global health disparities, Prof. Mulder highlights how Diabetologia remains at the forefront of the field. He also shares his excitement about advancements in stem-cell and beta-cell research, the potential of precision medicine, and the role of incretin-based therapies, Prof. Mulder previews Diabetologia's special symposium on technology in diabetes care, co-created with patients, and explores how collaborative efforts are driving innovation in treatment and care. Join us for this inspiring conversation about the future of diabetes research and care.

  --------  

  9:45

Weitere Wissenschaft Podcasts

Trending Wissenschaft Podcasts

Über Diabetes Insights - Breakthroughs and Innovators